Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event
February 13, 2013
Almac, leading provider of contract services to the global Pharmaceutical and Biotech industries, will play a key role in delivering industry insight on the topic of Supply Chain Management at this year’s 14th Annual CTS Europe event, taking place 26-27th February in Berlin.
The event offers attendees peer-delivered case studies, extensive networking opportunities and the most current industry insight. It will provide a platform for Almac’s Dr. Mike Hutton to deliver a presentation entitled: “Smart Standardization for IVRS/IWRS: Determining a Standard Approach while still Retaining Flexibility”” Supply Chain Management Expert Martin McGlone will be onsite for one-to-one consultations throughout the duration of the two day conference.
Looking forward to the event, Mr McGlone commented; “Almac has been listening to its client’s needs and we are committed to delivering innovative and cost-effective solutions in line with trial timelines through the use of market-leading technologies (IXRS) and our dedicated Supply Chain Management personnel,“ adding “We are delighted to be attending CTS Europe again this year to share thoughts on delivering efficiencies in the clinical trial supply chain with our industry colleagues.”
Notes to Editors
The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.